Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
2,716,053
-
Share change
-
-324,622
-
Total reported value
-
$116,727,065
-
Put/Call ratio
-
10%
-
Price per share
-
$42.98
-
Number of holders
-
71
-
Value change
-
-$13,254,416
-
Number of buys
-
36
-
Number of sells
-
32
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q2 2020
As of 30 Jun 2020 SPDR SERIES TRUST - S&P PHARMAC (XPH) had 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,716,053 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, MORGAN STANLEY, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, Wharton Business Group, LLC, COMMONWEALTH EQUITY SERVICES, LLC, Financial Management Professionals, Inc., LPL Financial LLC, Hochman Cole Investment Advisors, Inc., and WELLS FARGO & COMPANY/MN.
This table shows 71 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.